chr6-52454150-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000371068.11(EFHC1):c.779G>A(p.Arg260Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000413 in 1,613,938 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R260W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000371068.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC1 | NM_018100.4 | c.779G>A | p.Arg260Gln | missense_variant | 5/11 | ENST00000371068.11 | NP_060570.2 | |
EFHC1 | NM_001172420.2 | c.722G>A | p.Arg241Gln | missense_variant | 6/12 | NP_001165891.1 | ||
EFHC1 | NR_033327.2 | n.2105G>A | non_coding_transcript_exon_variant | 4/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFHC1 | ENST00000371068.11 | c.779G>A | p.Arg260Gln | missense_variant | 5/11 | 1 | NM_018100.4 | ENSP00000360107 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000165 AC: 25AN: 151972Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000370 AC: 93AN: 251404Hom.: 2 AF XY: 0.000464 AC XY: 63AN XY: 135866
GnomAD4 exome AF: 0.000439 AC: 642AN: 1461848Hom.: 4 Cov.: 34 AF XY: 0.000507 AC XY: 369AN XY: 727228
GnomAD4 genome AF: 0.000164 AC: 25AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74384
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 12, 2024 | Variant summary: EFHC1 c.779G>A (p.Arg260Gln) results in a conservative amino acid change located in the DM10 domain (IPR006602) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00041 in 1613938 control chromosomes, predominantly at a frequency of 0.0018 within the South Asian subpopulation in the gnomAD database, including 4 homozygotes (gnomAD v4.1.0). c.779G>A has been reported in the literature in at least an individual affected with Juvenile Myoclonic Epilepsy (example: Thounaojam_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Juvenile Myoclonic Epilepsy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34426522, 29750216). ClinVar contains an entry for this variant (Variation ID: 205389). Based on the evidence outlined above, the variant was classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 09, 2017 | - - |
Juvenile myoclonic epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2015 | p.Arg260Gln (CGG>CAG): c.779 G>A in exon 5 of the EFHC1 gene (NM_018100.3). The R260Q variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The R260Q variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not highly conserved across species within the second DM10 domain of the protein and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in CHILD-EPI panel(s). - |
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 04, 2022 | - - |
EFHC1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at